FI894169A - Förfarande för framställning av farmakologiskt värdefullt pyrrolo/3,2,1-jk//1,4/bensodiazepinderivat - Google Patents

Förfarande för framställning av farmakologiskt värdefullt pyrrolo/3,2,1-jk//1,4/bensodiazepinderivat Download PDF

Info

Publication number
FI894169A
FI894169A FI894169A FI894169A FI894169A FI 894169 A FI894169 A FI 894169A FI 894169 A FI894169 A FI 894169A FI 894169 A FI894169 A FI 894169A FI 894169 A FI894169 A FI 894169A
Authority
FI
Finland
Prior art keywords
pyrrolo
preparation
benzodiazepine derivative
pharmacologically valuable
pharmacologically
Prior art date
Application number
FI894169A
Other languages
English (en)
Finnish (fi)
Other versions
FI92401B (sv
FI92401C (sv
FI894169A0 (sv
Inventor
Yoshinari Sato
Teruaki Matuo
Takamoto Ogahara
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888821257A external-priority patent/GB8821257D0/en
Priority claimed from GB888829265A external-priority patent/GB8829265D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI894169A0 publication Critical patent/FI894169A0/sv
Publication of FI894169A publication Critical patent/FI894169A/sv
Publication of FI92401B publication Critical patent/FI92401B/sv
Application granted granted Critical
Publication of FI92401C publication Critical patent/FI92401C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI894169A 1988-09-09 1989-09-05 Förfarande för framställning av farmakologiskt värdefullt pyrrolo/3,2,1-jk//1,4/bensodiazepinderivat FI92401C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8821257 1988-09-09
GB888821257A GB8821257D0 (en) 1988-09-09 1988-09-09 Tricyclic compounds
GB8829265 1988-12-15
GB888829265A GB8829265D0 (en) 1988-12-15 1988-12-15 Tricyclic compounds

Publications (4)

Publication Number Publication Date
FI894169A0 FI894169A0 (sv) 1989-09-05
FI894169A true FI894169A (sv) 1990-03-10
FI92401B FI92401B (sv) 1994-07-29
FI92401C FI92401C (sv) 1994-11-10

Family

ID=26294376

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894169A FI92401C (sv) 1988-09-09 1989-09-05 Förfarande för framställning av farmakologiskt värdefullt pyrrolo/3,2,1-jk//1,4/bensodiazepinderivat

Country Status (18)

Country Link
US (2) US4981847A (sv)
EP (1) EP0360079B1 (sv)
JP (3) JPH0665673B2 (sv)
KR (1) KR900004737A (sv)
CN (1) CN1022187C (sv)
AU (1) AU628370B2 (sv)
DE (1) DE68912858T2 (sv)
DK (1) DK444789A (sv)
ES (1) ES2061848T3 (sv)
FI (1) FI92401C (sv)
HK (1) HK101996A (sv)
HU (2) HUT54152A (sv)
IE (1) IE62916B1 (sv)
IL (1) IL91361A (sv)
NO (1) NO171913C (sv)
PH (1) PH27358A (sv)
PT (1) PT91664B (sv)
RU (1) RU2007406C1 (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them
US5248679A (en) * 1988-09-09 1993-09-28 Fujisawa Pharmaceutical Co., Ltd. Tricyclic compounds
PH26955A (en) * 1989-03-08 1992-12-03 Kali Chemie Pharma Gmbh Novel 1,7-fused 1H-indole-2-carboxylic acid N-(1,4-benzodiazepin-3-YL) amides
FR2652352A1 (fr) * 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
GB9018601D0 (en) * 1990-08-24 1990-10-10 Fujisawa Pharmaceutical Co Tricyclic compounds
CA2056809A1 (en) * 1990-12-07 1992-06-08 Mark G. Bock Benzodiazepine analogs
EP0572235A3 (en) * 1992-05-28 1994-06-01 Tanabe Seiyaku Co Beta-carboline derivatives with anticholecystoquinine activity
GB2271354A (en) * 1992-10-07 1994-04-13 Merck Sharp & Dohme Tricyclic derivatives of benzodiazepines
CA2157383A1 (en) * 1993-03-03 1994-09-15 Shinichi Fukuyama Optical isomerization inhibitor
PT731091E (pt) * 1993-11-26 2002-05-31 Tanabe Seiyaku Co Derivados de 2-oxoindolina como antagonistas do receptor de colecistoquinina
EP0804425A2 (en) * 1994-07-29 1997-11-05 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
WO1996006617A1 (en) * 1994-08-30 1996-03-07 Fujisawa Pharmaceutical Co., Ltd. Liposome preparation
FR2725719B1 (fr) * 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv
US5716958A (en) 1994-10-27 1998-02-10 Tobishi Pharmaceutical Co., Ltd. Amino acid derivative having anti-CCK activity
AUPO284396A0 (en) 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
FR2776660B1 (fr) * 1998-03-27 2000-05-12 Parke Davis Diazepino-indoles de phosphodiesterases iv
EP2897944B1 (en) 2012-09-21 2016-10-26 Bristol-Myers Squibb Company Substituted 1,5-benzodiazepinone compounds
WO2014047374A1 (en) 2012-09-21 2014-03-27 Bristol-Myers Squibb Company Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
EP2897942B1 (en) 2012-09-21 2016-08-31 Bristol-Myers Squibb Company Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch inhibitors
JP2015531792A (ja) 2012-09-21 2015-11-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ １，４−ベンゾジアゼピノン化合物のプロドラッグ
US9133139B2 (en) 2012-09-21 2015-09-15 Bristol-Myers Squibb Company Fluoroalkyl-1,4-benzodiazepinone compounds
US9242940B2 (en) 2012-09-21 2016-01-26 Bristol-Myers Squibb Company N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds
EP2897938B1 (en) 2012-09-21 2017-03-15 Bristol-Myers Squibb Company Fluoroalkyl dibenzodiazepinone compounds
US9249157B2 (en) 2012-09-21 2016-02-02 Bristol-Myers Squibb Company Tricyclic heterocycle compounds
US9492469B2 (en) 2013-04-04 2016-11-15 Bristol-Myers Squibb Company Combination therapy for the treatment of proliferative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3651083A (en) * 1969-11-03 1972-03-21 Upjohn Co Tetra- and hexahydro-phenylpyrrolo benzodiazepines and intermediates
US3794646A (en) * 1970-04-14 1974-02-26 Robins Co Inc A H 5,7-disubstituted-1,9-tetramethylene-1,4-benzodiazepin-2-ones
AU2733371A (en) * 1970-04-14 1972-10-12 A. H. Robins Company, Incorporated 5, 7-DISUBSTITUTED-l, 9-ALKYLENE-l, 4-BENZODIAZEPIN-2 ONES
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
US4735941A (en) * 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
DK444789A (da) 1990-03-10
HK101996A (en) 1996-06-21
NO893616D0 (no) 1989-09-08
HU211264A9 (en) 1995-11-28
NO171913C (no) 1993-05-19
JPH02111774A (ja) 1990-04-24
IE892840L (en) 1990-03-09
JPH0748373A (ja) 1995-02-21
DE68912858D1 (de) 1994-03-17
IL91361A0 (en) 1990-03-19
AU4025789A (en) 1990-03-15
JP2848230B2 (ja) 1999-01-20
FI92401B (sv) 1994-07-29
HUT54152A (en) 1991-01-28
JPH0665673B2 (ja) 1994-08-24
NO893616L (no) 1990-03-12
RU2007406C1 (ru) 1994-02-15
FI92401C (sv) 1994-11-10
EP0360079B1 (en) 1994-02-02
US4981847A (en) 1991-01-01
NO171913B (no) 1993-02-08
DE68912858T2 (de) 1994-06-01
US5155101A (en) 1992-10-13
FI894169A0 (sv) 1989-09-05
AU628370B2 (en) 1992-09-17
EP0360079A1 (en) 1990-03-28
CN1022187C (zh) 1993-09-22
KR900004737A (ko) 1990-04-12
PH27358A (en) 1993-06-21
PT91664B (pt) 1995-05-31
PT91664A (pt) 1990-03-30
IL91361A (en) 1994-10-07
IE62916B1 (en) 1995-03-08
DK444789D0 (da) 1989-09-08
JPH0741480A (ja) 1995-02-10
CN1040981A (zh) 1990-04-04
ES2061848T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
FI894169A (sv) Förfarande för framställning av farmakologiskt värdefullt pyrrolo/3,2,1-jk//1,4/bensodiazepinderivat
FI890282A (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
FI973543A0 (sv) Förfarande för framställning av heteromultimeriska polypeptider
FI92934B (sv) Analogiförfarande för framställning av terapeutiskt användbara 1-deoxinojirimycinderivat
HU908147D0 (en) Process for the production of n-(pyrrolo/2,3-d/pyrimidine-3-yl-acyl)-glutamine-acid derivatives
FI891538A (sv) Förfarande för framställning av farmaceutiskt användbara fenolsubstituerade gem-difosfonatderivat
FI903225A0 (sv) Förfarande för framställning av terapeutiskt värdefullt 5,11-dihydro-6H-dipyrido/3,2-b:2',3'-e/ /1,4/diazepin-6-on
FI981709A0 (sv) Förfarande för framställning av 5-substituerade 2-amino-4-oxo-pyrrolo/2,3-d/-pyrimidiner
FI104171B (sv) Förfarande för framställning av mono-N-alkylerade polyazamakrocykliska föreningar
FI900897A0 (sv) Analogiförfande för framställning av terapeutiskt användbara 4,5,6,7-tetrahydroimidazo/4,5,1-jk//1,4/bensodiazepin-2(1H)-tionderivat
FI880467A (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
FI885290A (sv) Förfarande för framställning av farmakologiskt värdefull indanderivat
HU9300488D0 (en) Tricyclic benzodiazepine derivatives
FI103727B1 (sv) Förfarande för framställning av terapeutiskt användbara 2-amino-4-substituerad-fenyl-4H-pyrano[3,2-h]kinolin-3-karbonitriler
FI892684A0 (sv) Förfarande för framställning av terapeutiskt aktiva 4-oxo-imidazo/1,5-a/kinoxalinderivat
PL327539A1 (en) 2,7-substituted derivatives of octahydropyrrole[1,2-a]-pyrazine
FI905051A0 (sv) Förfaranden för framställning av farmakologiskt värdefulla alkylfosfonoseriner
FI973644A (sv) Nytt förfarande för framställning av 2,3-dihydrobenzofuranolderivat
FI900145A (sv) Förfarande för framställning av farmaceutiskt användbara 1,1-dioxo-cefem-4-karbotiolsyraderivat
FI88168C (sv) Förfarande för framställning av 3'-demetoxiepipodofyllotoxinglukosidde rivat
FI910448A0 (sv) Förfarande för framställning av terapeutiskt användbara 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimetyl-pyrrolo/2,3-b/indolderivat
FI890711A (sv) Förfarande för framställning av farmakologiskt värdefulla fenoxi-etylaminderivat
FI953361A0 (sv) Förfarande för framställning av substituerade indolonderivat
FI893115A0 (sv) Analogiförfarande för framställning av terapeutiskt användbara mitomycinfosfatderivat
FI894812A0 (sv) Förfarande för framställning av farmakologiskt värdefulla 2-karbonylsubstituerade N,N'-di(trimetoxibensoyl)piperaziner

Legal Events

Date Code Title Description
FG Patent granted

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.

BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.